Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.11 USD
Change Today -0.36 / -5.56%
Volume 294.5K
RTIX On Other Exchanges
As of 3:47 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

rti surgical inc (RTIX) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/22/15 - $7.11
52 Week Low
10/23/14 - $3.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for RTI SURGICAL INC (RTIX)

rti surgical inc (RTIX) Related Bloomberg News

View More Bloomberg News

rti surgical inc (RTIX) Related Businessweek News

No Related Businessweek News Found

rti surgical inc (RTIX) Details

RTI Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes orthopedic and other surgical implants for use in various surgical procedures worldwide. The company provides natural tissue implants, as well as metal and synthetic implants for the treatment of spinal and other orthopedic disorders. It processes donated human musculoskeletal and other tissues, including bone, cartilage, tendons, ligaments, fascia lata, pericardium, sclera, cornea, and dermal tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company’s implants are used in the fields of spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic, surgical specialties, and dental. RTI Surgical, Inc. markets its products through its direct distribution force, as well as through a network of independent distributors to hospitals and surgeons. The company was formerly known as RTI Biologics, Inc. and changed its name to RTI Surgical, Inc. in July 2013. RTI Surgical, Inc. was founded in 1997 and is headquartered in Alachua, Florida.

1,102 Employees
Last Reported Date: 03/4/15
Founded in 1997

rti surgical inc (RTIX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $550.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $336.0K
Executive Vice President of Tissue-Based Impl...
Total Annual Compensation: $330.0K
Chief Scientific Officer and Executive Vice P...
Total Annual Compensation: $334.0K
Corporate Secretary
Total Annual Compensation: $330.0K
Compensation as of Fiscal Year 2014.

rti surgical inc (RTIX) Key Developments

RTI Surgical, Inc. Enters into Third Amendment to Second Amended and Restated Loan Agreement

On June 29, 2015, RTI Surgical Inc. entered into a Third Amendment to the Second Amended and Restated Loan Agreement, dated as of July 16, 2013, among the company, as Borrower, TD Bank, N.A. and Regions Bank, as Lenders, and TD Bank, N.A., as administrative agent for the Lenders. The parties to the Loan Agreement entered into the Amendment in order to: increase the Maximum Revolving Credit Amount from Twenty Million and 00/100 Dollars $20,000,000.00 to Thirty Million and 00/100 Dollars $30,000,000.00; and make certain corresponding amendments.

RTI Surgical Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Second Quarter of 2015; Revises Earnings Guidance for the Full Year of 2015

RTI Surgical Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenue of $68,034,000 against $60,745,000 a year ago. Operating income was $6,164,000 against loss of $3,488,000 a year ago. Income before income tax benefit was $5,870,000 against loss before income tax provision of $3,843,000 a year ago. Net income was $3,742,000 against loss of $2,310,000 a year ago. Net income applicable to common shares was $2,934,000 or $0.05 basic and diluted per share against loss of $3,060,000 or $0.05 basic and diluted per share a year ago. EBITDA was $9,3443,000 against LBITDA of $596,000 a year ago. Adjusted EBITDA was $10,703,000 against $6,374,000 a year ago. Adjusted net income was $2,934,000 or $0.05 diluted per share against $407,000 or $0.01 diluted per share a year ago. Net cash provided by operating activities was $1,006,000 against net cash used in operating activities of $3,307,000 a year ago. Purchases of property, plant and equipment were $4,265,000 against $4,936,000 a year ago. Patent and acquired intangible asset costs were $22,000 against $217,000 a year ago. For the second quarter of 2015, the company expects revenues to be between $70 million and $71 million, and net income per fully diluted common share to be approximately $0.04, based on 58.2 million fully diluted shares outstanding. Based on results from the first quarter, the company is raising full year guidance for 2015. The company now expects full year revenues for 2015 to be between $281 million and $286 million, as compared to prior guidance of between $279 million and $285 million. Full year net income per fully diluted common share is expected to be in the range of $0.19 to $0.23 based on 58.2 million fully diluted common shares outstanding, as compared to prior guidance of $0.17 to $0.22.

RTI Surgical Inc. Presents at UBS Global Healthcare Conference, May-18-2015 03:00 PM

RTI Surgical Inc. Presents at UBS Global Healthcare Conference, May-18-2015 03:00 PM. Venue: Sheraton New York Times Square Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Robert P. Jordheim, Chief Financial Officer and Executive Vice President.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RTIX:US $6.11 USD -0.36

RTIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.35 USD -0.01
AngioDynamics Inc $16.35 USD +0.005
Exactech Inc $20.92 USD -0.14
Orthofix International NV $31.98 USD -0.82
SeaSpine Holdings Corp $16.33 USD -0.49
View Industry Companies

Industry Analysis


Industry Average

Valuation RTIX Industry Range
Price/Earnings 64.4x
Price/Sales 1.3x
Price/Book 2.1x
Price/Cash Flow 41.2x
TEV/Sales 0.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RTI SURGICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at